# Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders

> **NCT00101764** · PHASE1 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 120 (—)

## Conditions studied

- Macular Degeneration
- Retinal Vein Occlusion
- Diabetic Retinopathy

## Interventions

- **DRUG:** Triamcinolone Acetonide

## Key facts

- **NCT ID:** NCT00101764
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01-05
- **Primary completion:** —
- **Final completion:** 2008-05-20
- **Target enrollment:** 120 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00101764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00101764, "Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00101764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*